NCT02215226View on ClinicalTrials.gov

GBS Sero-correlate of Protection

CompletedOBSERVATIONAL
Enrollment

35,274

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 9, 2016

Study Completion Date

December 31, 2016

Conditions
Invasive Group B Streptococcus Disease
Trial Locations (1)

2013

Respiratory and Meningeal Pathogen Research Unit, Soweto, Johannesburg

Sponsors

Collaborators (1)

Novartis Vaccines
All Listed Sponsors
collaborator

Novartis Vaccines

INDUSTRY

lead

University of Witwatersrand, South Africa

OTHER